Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42

[1]  O. Wilhelm,et al.  Online Supplemental Material , 2018 .

[2]  M. Muche,et al.  The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity. , 2009, Matrix biology : journal of the International Society for Matrix Biology.

[3]  I. Campbell,et al.  Identification and structural analysis of type I collagen sites in complex with fibronectin fragments , 2009, Proceedings of the National Academy of Sciences.

[4]  C. Overall,et al.  The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B. , 2009, Journal of molecular biology.

[5]  Robert P. Hammer,et al.  Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition* , 2008, Journal of Biological Chemistry.

[6]  H. Emonard,et al.  Collagen-binding domains of gelatinase A and thrombospondin-derived peptides impede endocytic clearance of active gelatinase A and promote HT1080 fibrosarcoma cell invasion. , 2008, Life sciences.

[7]  B. Fingleton.  MMPs as therapeutic targets--still a viable option? , 2008, Seminars in cell & developmental biology.

[8]  L. Matrisian,et al.  The other side of MMPs: Protective roles in tumor progression , 2007, Cancer and Metastasis Reviews.

[9]  L. Bonewald,et al.  Inhibition of MMP-2 gelatinolysis by targeting exodomain-substrate interactions. , 2007, The Biochemical journal.

[10]  E. Roeb,et al.  Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. , 2007, Journal of hepatology.

[11]  Christopher M. Overall,et al.  In search of partners: linking extracellular proteases to substrates , 2007, Nature Reviews Molecular Cell Biology.

[12]  A. Rowan,et al.  Activity of matrix metalloproteinase‐9 against native collagen types I and III , 2007, The FEBS journal.

[13]  W. Ouwehand,et al.  Structural Basis for the Platelet-Collagen Interaction , 2007, Journal of Biological Chemistry.

[14]  K. Brew,et al.  The Roles of Substrate Thermal Stability and P2 and P1′ Subsite Identity on Matrix Metalloproteinase Triple-helical Peptidase Activity and Collagen Specificity* , 2006, Journal of Biological Chemistry.

[15]  K. Kar,et al.  Self-association of Collagen Triple Helic Peptides into Higher Order Structures* , 2006, Journal of Biological Chemistry.

[16]  E. Koivunen,et al.  Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. , 2006, Blood.

[17]  D. Schuppan,et al.  Halofuginone Induces Matrix Metalloproteinases in Rat Hepatic Stellate Cells via Activation of p38 and NFκB* , 2006, Journal of Biological Chemistry.

[18]  K. Shiraki,et al.  Matrix metalloproteinase, hepatocyte growth factor, and tissue inhibitor of matrix metalloproteinase during human liver regeneration , 2006, Liver international (Print).

[19]  M. Björklund,et al.  Gelatinase-mediated migration and invasion of cancer cells. , 2005, Biochimica et biophysica acta.

[20]  J. Ramshaw,et al.  Prediction of Collagen Stability from Amino Acid Sequence* , 2005, Journal of Biological Chemistry.

[21]  Hedvig Tordai,et al.  Hydroxamate-based peptide inhibitors of matrix metalloprotease 2. , 2005, Biochimie.

[22]  M. Llinás,et al.  Modular Autonomy, Ligand Specificity, and Functional Cooperativity of the Three In-tandem Fibronectin Type II Repeats from Human Matrix Metalloproteinase 2* , 2004, Journal of Biological Chemistry.

[23]  J. Iredale,et al.  Expression of matrix metalloproteinase‐2 and ‐14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[24]  G. Fields,et al.  Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[25]  W. Frederiks,et al.  Metabolic Mapping of Proteinase Activity with Emphasis on In Situ Zymography of Gelatinases , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  X. Puente,et al.  Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.

[27]  W. Frederiks,et al.  In Situ Localization of Gelatinolytic Activity in the Extracellular Matrix of Metastases of Colon Cancer in Rat Liver Using Quenched Fluorogenic DQ-gelatin , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  D. Schuppan,et al.  The Epithelial Mitogen Keratinocyte Growth Factor Binds to Collagens via the Consensus Sequence Glycine-Proline-Hydroxyproline* , 2002, The Journal of Biological Chemistry.

[29]  B. Marmer,et al.  Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact Propeptide* , 2002, The Journal of Biological Chemistry.

[30]  I. Okazaki,et al.  Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. , 2001, Journal of hepatology.

[31]  C. Ruhrberg,et al.  Endogenous inhibitors of angiogenesis. , 2001, Journal of cell science.

[32]  M. Llinás,et al.  Gelatin-binding Region of Human Matrix Metalloproteinase-2 , 2001, The Journal of Biological Chemistry.

[33]  M. Stack,et al.  Type I collagen stabilization of matrix metalloproteinase-2. , 2001, Archives of biochemistry and biophysics.

[34]  Richard Mayne,et al.  Multiple Binding Sites in Collagen Type I for the Integrins α1β1 and α2β1 * , 2000, The Journal of Biological Chemistry.

[35]  Y. Tominaga,et al.  Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. , 2000, Chemistry & biology.

[36]  G. Schneider,et al.  Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. , 1999, Science.

[37]  R. Farndale,et al.  Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. , 1999, Cardiovascular research.

[38]  C. Overall,et al.  The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation* , 1998, The Journal of Biological Chemistry.

[39]  G. Butler,et al.  The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.

[40]  L. Patthy,et al.  Structure and Domain-Domain Interactions of the Gelatin-binding Site of Human 72-Kilodalton Type IV Collagenase (Gelatinase A, Matrix Metalloproteinase 2) (*) , 1996, The Journal of Biological Chemistry.

[41]  E. Monzani,et al.  Type I collagen CNBr peptides: species and behavior in solution. , 1996, Biochemistry.

[42]  P. Barker,et al.  Binding of gelatinases A and B to type-I collagen and other matrix components. , 1995, The Biochemical journal.

[43]  J. Feige,et al.  Crinopexy: extracellular regulation of growth factor action. , 1995, Kidney international. Supplement.

[44]  C. Overall,et al.  Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen , 1995, The Journal of Biological Chemistry.

[45]  James P. Quigley,et al.  Matrix Metalloproteinase-2 Is an Interstitial Collagenase , 1995, The Journal of Biological Chemistry.

[46]  W. Stetler-Stevenson,et al.  Autolytic activation of recombinant human 72 kilodalton type IV collagenase. , 1995, Biochemistry.

[47]  G Murphy,et al.  A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.

[48]  E. Howard,et al.  Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. , 1991, The Journal of biological chemistry.

[49]  I. Sagi,et al.  Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition? , 2010, Biochimica et biophysica acta.

[50]  M. Pinzani,et al.  Fibrogenesis & Tissue Repair , 2009 .

[51]  C. Overall.  Matrix metalloproteinase substrate binding domains, modules and exosites. Overview and experimental strategies. , 2001, Methods in molecular biology.

[52]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[53]  C. Overall.  Matrix MetaIIoproteinase Substrate Binding Domains, Modules and Exosites , 2001 .

[54]  J. Quigley,et al.  Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. , 1995, The Journal of biological chemistry.

[55]  P. Matsudaira.  Limited N-terminal sequence analysis. , 1990, Methods in enzymology.